-
Araris and Chugai enter ADC licensing agreement
Araris Biotech AG and Chugai Pharmaceutical Co., Ltd. announced the licensing of AraLinQ® technology for developing innovative ADC cancer therapies. By combining Araris’ conjugation platform with Chugai’s antibody engineering expertise, the collaboration aims to enhance treatment precision and tolerability. The partners view this milestone as a key step toward advancing the program into clinical development.
-
Peter Steiner is the new managing director of «grow cluster»
The Board of Trustees of the «grow cluster» has appointed Dr. Peter Steiner as its new Managing Director. The biotechnologist and experienced entrepreneur took up his post on November 1, 2025, and is currently being introduced to his new role by the previous Managing Director, Dr. Dolf van Loon. Steiner will take over the management…
-
Two grow cluster startups in the «Top 100 Swiss Startups»
Two companies from grow cluster have once again made it into the Top 100 Swiss Startups ranking: Navignostics (Horgen) and GlycoEra (Wädenswil). We congratulate both teams on this success and are proud to have such strong, pioneering companies in our network.
-
grow cluster introduced itself to international guests
Last week, the Greater Zurich Area (GZA) visited Wädenswil with teams from Zurich, the US, and China. The GZA is the official point of contact for international companies looking to expand into the Zurich economic area.
-
Araris Biotech wins Strüngmann Award 2025
The grow company Araris Biotech, based in Au/Wädenswil, has been honoured with the prestigious Strüngmann Award 2025.
-
That was the «grow-Apéro» 2025
New CEO for ‘grow cluster’, new locations for the ZHAW and an SOB stop for the Tuwag-Areal – these and other news were presented at the traditional grow aperitif on 1 July.
-
Araris nominated for Strüngmann Award
The grow-company Araris Biotech AG has been nominated as one of three companies for the Strüngmann Award. The winning team will be announced on 3 July and will receive prize money of EUR 100,000.
-
ClycoEra AG with successful financing round
The grow company GlycoEra AG, based on the Tuwag-Areal in Wädenswil, has completed an oversubscribed Series B financing round totalling 130 million US dollars.
-
Grow-Apéro
We are delighted to invite you to the grow-Apéro on 1 July 2025. A warm welcome to you!
